Literature DB >> 29467998

Immunophenotypic Characteristics of T-Acute Lymphoblastic Leukemia in Omani Patients: A Correlation with Demographic Factors.

Azza Al-Mashaikhi1, Zahra Al Khatri1, Sahima Al Mamari2, Murtadha Al Khabori2, Anil Pathare2, Naglaa Fawaz1,3.   

Abstract

OBJECTIVES: To study and classify the immunophenotypic characteristics of Omani patients diagnosed with T-cell acute lymphoblastic leukemia (T-ALL) and to correlate the results with age and gender as well as biological factors (peripheral and bone marrow blast cells percentage).
METHODS: Fifty cases from both genders and of all ages who fulfilled the inclusion criteria with a diagnosis of T-ALL were included in the study. Correlation of T-ALL subtypes with age, gender, and initial bone marrow and peripheral blood blast cells percentage was assessed using ANOVA.
RESULTS: Among the 50 T-ALL patients analyzed, 44 were male and six were female giving a male-to-female ratio of 7:1 (p = 0.007). The average age of patients was 19.2 years with no significant differences in the three disease subtypes. No significant association was seen between the peripheral or bone marrow blast cell percentage and the differentiation stages of the neoplastic clone of T-ALL. All female patients were found to express an immature T-ALL phenotype.
CONCLUSIONS: This study reports the subtypes of T-ALL in Oman for the first time. It is hoped that this will lead to a better understanding of the disease outcomes.

Entities:  

Keywords:  Acute Lymphoblastic Leukemia; Immunophenotyping; Oman; T-cells

Year:  2018        PMID: 29467998      PMCID: PMC5798795          DOI: 10.5001/omj.2018.08

Source DB:  PubMed          Journal:  Oman Med J        ISSN: 1999-768X


  16 in total

1.  Prognostic impact of age in children and adolescents with acute lymphoblastic leukemia: data from the trials ALL-BFM 86, 90, and 95.

Authors:  A Möricke; M Zimmermann; A Reiter; H Gadner; E Odenwald; J Harbott; W-D Ludwig; H Riehm; M Schrappe
Journal:  Klin Padiatr       Date:  2005 Nov-Dec       Impact factor: 1.349

2.  Risk of adverse events after completion of therapy for childhood acute lymphoblastic leukemia.

Authors:  Ching-Hon Pui; Deqing Pei; John T Sandlund; Dario Campana; Raul C Ribeiro; Bassem I Razzouk; Jeffrey E Rubnitz; Scott C Howard; Nobuko Hijiya; Sima Jeha; Cheng Cheng; James R Downing; William E Evans; Mary V Relling; Melissa Hudson
Journal:  J Clin Oncol       Date:  2005-11-01       Impact factor: 44.544

3.  Immunological subtypes of childhood acute lymphoblastic leukemia in Bulgaria.

Authors:  H Taskov; E Dimitrova; M Serbinova; L Mendisova; D Bobev
Journal:  Leuk Res       Date:  1995-11       Impact factor: 3.156

4.  Multimarker phenotypic characterization of adult and childhood acute lymphoblastic leukaemia: an Italian multicentre study.

Authors:  R Foà; L Baldini; G Cattoretti; P Foa; M Gobbi; F Lauria; E Madon; G Masera; R Miniero; P Paolucci
Journal:  Br J Haematol       Date:  1985-10       Impact factor: 6.998

5.  Pediatric-inspired therapy in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: the GRAALL-2003 study.

Authors:  Françoise Huguet; Thibaut Leguay; Emmanuel Raffoux; Xavier Thomas; Kheira Beldjord; Eric Delabesse; Patrice Chevallier; Agnes Buzyn; André Delannoy; Yves Chalandon; Jean-Paul Vernant; Marina Lafage-Pochitaloff; Agnès Chassevent; Véronique Lhéritier; Elizabeth Macintyre; Marie-Christine Béné; Norbert Ifrah; Hervé Dombret
Journal:  J Clin Oncol       Date:  2009-01-05       Impact factor: 44.544

6.  Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL).

Authors:  M C Bene; G Castoldi; W Knapp; W D Ludwig; E Matutes; A Orfao; M B van't Veer
Journal:  Leukemia       Date:  1995-10       Impact factor: 11.528

7.  Relapsed acute leukemia in children: Oman experience.

Authors:  Zakia al Lamki; Yasser A Wali; Wasifuddin M Shah; Mathew Zachariah
Journal:  Pediatr Hematol Oncol       Date:  2004-03       Impact factor: 1.969

Review 8.  The genetics and molecular biology of T-ALL.

Authors:  Tiziana Girardi; Carmen Vicente; Jan Cools; Kim De Keersmaecker
Journal:  Blood       Date:  2017-01-23       Impact factor: 22.113

9.  Long-term results of St Jude Total Therapy Studies 11, 12, 13A, 13B, and 14 for childhood acute lymphoblastic leukemia.

Authors:  C H Pui; D Pei; J T Sandlund; R C Ribeiro; J E Rubnitz; S C Raimondi; M Onciu; D Campana; L E Kun; S Jeha; C Cheng; S C Howard; M L Metzger; D Bhojwani; J R Downing; W E Evans; M V Relling
Journal:  Leukemia       Date:  2009-12-10       Impact factor: 11.528

10.  Prognostic significance of leukopenia in childhood acute lymphoblastic leukemia.

Authors:  Yusuke Shiozawa; Junko Takita; Motohiro Kato; Manabu Sotomatsu; Katsuyoshi Koh; Kohmei Ida; Yasuhide Hayashi
Journal:  Oncol Lett       Date:  2014-01-24       Impact factor: 2.967

View more
  1 in total

1.  Prognostic miRNA classifiers in t cell acute lymphoblastic leukemia: Study protocol for a systematic review and meta-analysis of observational clinical studies.

Authors:  Shanthi Sabarimurugan; Madhav Madurantakam Royam; Chellan Kumarasamy; Gothandam Kodiveri Muthukaliannan; Suja Samiappan; Rama Jayaraj
Journal:  Medicine (Baltimore)       Date:  2019-03       Impact factor: 1.889

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.